MADRID, March 31 Spanish blood products company
Grifols has signed a 7-year, $375-million contract to
conduct blood analysis for Japan's Red Cross, the company said
in a statement to the stock market regulator on Monday.
The contract to analyze 5.3 million blood transfusions a
year for HIV and hepatitis and other infections was signed by
Grifols unit Novartis Pharma, the Spanish group said.
Grifols acquired the blood transfusion testing unit of
Novartis in January.
(Reporting by Paul Day; Editing by Fiona Ortiz)